About Organisation
Pfizer is the funder of this independent medical education grant programme, which supports organisations working in healthcare professional education and healthcare improvement. The programme focuses on strengthening healthcare professionals’ knowledge, skills, and confidence in Homologous Recombination Repair mutation (HRRm) testing for metastatic prostate cancer. Through this funding opportunity, Pfizer supports practical educational initiatives that help multidisciplinary healthcare teams apply guideline-based testing approaches in clinical practice. The programme particularly emphasizes education covering pre-analytical considerations, testing-related decision-making, interpretation of results, and communication of testing information throughout the patient care pathway.
About the Grant
The Pfizer HRRm Testing Education Grant supports independent medical education initiatives addressing knowledge, skill, and confidence gaps among healthcare professionals involved in HRRm testing for metastatic prostate cancer. Projects should develop practical competencies and support the application of guideline-based testing throughout the patient care pathway. Priority areas include pre-analytical considerations, multidisciplinary collaboration, clinical rationale, interpretation and communication of testing results, and biomarker-informed treatment decisions. Proposed programmes should demonstrate measurable educational impact and relevance to real-world clinical practice. Projects may use practical resources, case-based learning, clinical examples, and multidisciplinary educational approaches.
Who can Apply?
The grant is open to organisations involved in healthcare professional education or healthcare improvement. Eligible applicants include medical, dental, nursing, allied health, and pharmacy professional schools; healthcare institutions; professional organisations; medical societies; medical education companies; and other organisations with a relevant healthcare education or healthcare improvement mission. Individuals are not eligible to receive grants, and unaffiliated medical practice groups are also excluded. Applicants should apply through an eligible organisational entity. Strong proposals should demonstrate a clear educational need, practical approach, multidisciplinary relevance, meaningful learner outcomes, and a method for measuring educational impact.
How to Apply?
Eligible organisations should prepare an independent medical education proposal addressing identified gaps in HRRm testing knowledge, skills, or confidence among healthcare professionals. Proposals should explain the educational need, practical intervention, guideline-based approach, multidisciplinary relevance, expected learner outcomes, and evaluation methodology. Applicants should ensure their proposed activities address relevant HRRm testing areas and can be completed within the maximum 12-month project period. Applications should be submitted according to the programme requirements before the stated deadline.
Application Deadline
The last date to apply for the Pfizer Independent Medical Education Grant Program is 08 October 2026.
Last Date To Apply
For more information, please visit the grant website here.
